Medicamen Biotech standalone net profit rises 31.06% in the September 2021 quarter

Sales rise 5.69% to Rs 32.52 crore

Net profit of Medicamen Biotech rose 31.06% to Rs 4.22 crore in the quarter ended September 2021 as against Rs 3.22 crore during the previous quarter ended September 2020. Sales rose 5.69% to Rs 32.52 crore in the quarter ended September 2021 as against Rs 30.77 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales32.5230.77 6 OPM %19.1318.04 -PBDT6.405.30 21 PBT5.054.60 10 NP4.223.22 31

Powered by Capital Market - Live News